Rhonda Warren
Physician Assistant · Seattle, WANPI 1043888027
Payments from drug & device makers
Across 201 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$600
- Mayne Pharma Commercial LLC$363
- Novo Nordisk$355
- AstraZeneca$275
- Amgen$269
- Takeda Pharmaceuticals U.S.A., Inc.$204
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,317100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $600 |
| Mayne Pharma Commercial LLC | 28 | $363 |
| Novo Nordisk | 29 | $355 |
| AstraZeneca | 8 | $275 |
| Amgen | 14 | $269 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $204 |
| Lilly USA, LLC | 15 | $204 |
| Hologic Sales And Service, LLC | 4 | $101 |
| Johnson & Johnson | 4 | $94 |
| Boehringer Ingelheim | 3 | $73 |
| Abbott | 4 | $65 |
| Pfizer | 3 | $63 |
| Halozyme Inc | 3 | $57 |
| Antares Pharma, Inc. | 3 | $51 |
| Mylan Specialty L.p. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| GSK | 2 | $41 |
| Organon | 2 | $32 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Merck | 1 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $28 |
| Dexcom, Inc. | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Ascensia Diabetes Care US Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Alk-abello, Inc | 1 | $22 |
| Sanofi | 1 | $22 |
| Cleerly, Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Exact Sciences | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$125
- NEXTSTELLIS$125
How this compares
$3,317 in reported general payments places this provider in the 90th percentile of 2,741 physician assistant providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $21,118 |
| Levothyroxine Sodium | 30 | $287 |
| Ropinirole Hcl | 13 | $276 |
| Losartan Potassium | 21 | $170 |
| Trazodone Hcl | 19 | $123 |
| Paroxetine Hcl | 11 | $118 |
| Atorvastatin Calcium | 23 | $114 |
| Amlodipine Besylate | 19 | $92 |
| Pantoprazole Sodium | 14 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $355 | $21,11818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,741 physician assistant providers in Washington.
Other physician assistant in Seattle
- Erinn KingSeattle$129K
- Christy VathSeattle$75K
- Justin ChapinSeattle$40K
- Neil AndersonSeattle$13K
- Elena MartinezSeattle$12K
- Kari PaulsonSeattle$9K
- Jason LeganSeattle$8K
- Dwight MaceroSeattle$7K
- Paul AlgeoSeattle$7K
- Jill KandoraShoreline$437K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.